The enormous world of microorganism source antibiotics to mankind in the war against pathogenic microbes. These microbes in turn tilt the balance to their favor by acquiring resistance against antibiotics, through borrowed genes from a pool widely distributed in the microbial world itself. This collateral damage of misuse of antibiotics on one patient is not limited to that patient, but affects whole society, through expansion of environmental resistome. Both antibiotics and resistance are secondary metabolites involved in varied process, with existence history of million years. Therefore, any antibiotic that would be discovered in future, resistance against it would already be existing in microbial world, which will be acquired by the target bacteria sooner or later. The fight against infection cannot not be won with antibiotics, but truce may be attained through infection control and antibiotic stewardship.
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
For decades microbes, in particular bacteria, have become increasingly resistant to various antimicrobials.
The World Health Assembly’s endorsement of the Global Action Plan on Antimicrobial Resistance (AMR) in May 2015, and the Political Declaration of the High-Level Meeting of the General Assembly on AMR in September 2017, both recognize AMR as a global threat to public health.
These policy initiatives acknowledge overuse and misuse of antimicrobials as a main driver for development of resistance, as well as a need to optimize the use of antimicrobials.
The Global Action Plan on AMR sets out five strategic objectives as a blueprint for countries in developing national action plans (NAPs) on AMR:
Objective 1: Improve awareness and understanding of AMR through effective communication, education and training.
Objective 2: Strengthen the knowledge and evidence base through surveillance and research.
Objective 3: Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
Objective 4: Optimize the use of antimicrobial medicines in human and animal health.
Objective 5: Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Antimicrobial stewardship programmes optimize the use of antimicrobials, improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others.
Today, AMS is one of three “pillars” of an integrated approach to health systems strengthening. The other two are infection prevention and control (IPC) and medicine and patient safety.
Linking all three pillars to other key components of infection management and health systems strengthening, such as AMR surveillance and adequate supply of quality assured medicines, promotes equitable and quality health care towards the goal of achieving universal health coverage
CDC has defined “Antimicrobial stewardship” as-
The right antibiotic
for the right patient,
at the right time,
with the right dose, and
the right route, causing
the least harm to the patient and future patients
Why AMSP is needed?
Antimicrobial Resistance (AMR)
Misuse and Over-use of Antimicrobials
Widespread Use of Antimicrobials in Other Sectors
Poor Antimicrobial Research
IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM
Administrative Support (Leadership)
Formulating AMS Team
Infrastructure Support
Framing Antimicrobial Policy
Implementing AMS strategies
Education and Training
Should be publicly committed to the program.
Provide necessary funding and infrastructure support.
Multidisciplinary committee - responsible for framing, implementing and monitoring the compliance to antimicrobial policy of the hospital.
Led by the antimicrobial steward - infectious disease physician or infection control officer or clinical microbiologist.
Other members of AMS team - stewardship nurses
Antibiotics are drugs which have saved and still saving hundreds of thousands of lives every year. Antibiotics are possibly the most vital advancement in the history of medicine and undoubtedly; they are among medicine's most prevailing sector. But the other side of the coin offers us “antibiotic resistance” which is a serious and one of the most threatening healthcare problems worldwide
In India, bacteria that cause common infections, such as urinary tract and bloodstream infections, are becoming resistant to nearly all antibiotics. This resistance is due to a combination of factors: uncontrolled access to antibiotics, gaps in infection prevention and control (IPC) practices, and high rates of communicable diseases. Antibiotic resistance, or AR, is a serious problem throughout the country, and threatens to reduce the usefulness of antibiotics both in India and around the world.
Because of this emerging threat, India is committed to slowing the spread of AR. Two institutions within India’s Ministry of Health – the Indian Council of Medical Research and National Centre for Disease Control – each developed national networks of public and private hospitals to measure AR trends, prevent healthcare-associated infections (HAIs), and enhance appropriate use of antibiotics. The All India Institute of Medical Sciences is coordinating HAI measurement and prevention efforts in both networks. In addition, efforts in the state of Tamil Nadu focus on building district-level IPC capacity to prevent HAIs, focusing on maternal and neonatal patients.
The Indian Governamnet is is working closely with partners at the national and state level to:
Detect AR pathogens, including novel strains, by developing lab networks and lab expertise.
Use standardized surveillance to monitor and track AR infections in healthcare to learn how often these infections occur and to help develop strategies to prevent them.
Implement focused IPC activities and training.
Optimize use and reduce misuse of critical antibiotics through antibiotic stewardship programs.
Antibiotics
History and development of antibiotics
Decline of antibiotics
Bacteriophage: nature’s most abundant antibiotics
Phage specificity, resistance, transduction, lysis
Emergence of phages
Phage Case studies
Challenges to mainstream commercialization
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
For decades microbes, in particular bacteria, have become increasingly resistant to various antimicrobials.
The World Health Assembly’s endorsement of the Global Action Plan on Antimicrobial Resistance (AMR) in May 2015, and the Political Declaration of the High-Level Meeting of the General Assembly on AMR in September 2017, both recognize AMR as a global threat to public health.
These policy initiatives acknowledge overuse and misuse of antimicrobials as a main driver for development of resistance, as well as a need to optimize the use of antimicrobials.
The Global Action Plan on AMR sets out five strategic objectives as a blueprint for countries in developing national action plans (NAPs) on AMR:
Objective 1: Improve awareness and understanding of AMR through effective communication, education and training.
Objective 2: Strengthen the knowledge and evidence base through surveillance and research.
Objective 3: Reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures.
Objective 4: Optimize the use of antimicrobial medicines in human and animal health.
Objective 5: Develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.
Antimicrobial stewardship programmes optimize the use of antimicrobials, improve patient outcomes, reduce AMR and health-care-associated infections, and save health-care costs amongst others.
Today, AMS is one of three “pillars” of an integrated approach to health systems strengthening. The other two are infection prevention and control (IPC) and medicine and patient safety.
Linking all three pillars to other key components of infection management and health systems strengthening, such as AMR surveillance and adequate supply of quality assured medicines, promotes equitable and quality health care towards the goal of achieving universal health coverage
CDC has defined “Antimicrobial stewardship” as-
The right antibiotic
for the right patient,
at the right time,
with the right dose, and
the right route, causing
the least harm to the patient and future patients
Why AMSP is needed?
Antimicrobial Resistance (AMR)
Misuse and Over-use of Antimicrobials
Widespread Use of Antimicrobials in Other Sectors
Poor Antimicrobial Research
IMPLEMENTATION OF ANTIMICROBIAL STEWARDSHIP PROGRAM
Administrative Support (Leadership)
Formulating AMS Team
Infrastructure Support
Framing Antimicrobial Policy
Implementing AMS strategies
Education and Training
Should be publicly committed to the program.
Provide necessary funding and infrastructure support.
Multidisciplinary committee - responsible for framing, implementing and monitoring the compliance to antimicrobial policy of the hospital.
Led by the antimicrobial steward - infectious disease physician or infection control officer or clinical microbiologist.
Other members of AMS team - stewardship nurses
Antibiotics are drugs which have saved and still saving hundreds of thousands of lives every year. Antibiotics are possibly the most vital advancement in the history of medicine and undoubtedly; they are among medicine's most prevailing sector. But the other side of the coin offers us “antibiotic resistance” which is a serious and one of the most threatening healthcare problems worldwide
In India, bacteria that cause common infections, such as urinary tract and bloodstream infections, are becoming resistant to nearly all antibiotics. This resistance is due to a combination of factors: uncontrolled access to antibiotics, gaps in infection prevention and control (IPC) practices, and high rates of communicable diseases. Antibiotic resistance, or AR, is a serious problem throughout the country, and threatens to reduce the usefulness of antibiotics both in India and around the world.
Because of this emerging threat, India is committed to slowing the spread of AR. Two institutions within India’s Ministry of Health – the Indian Council of Medical Research and National Centre for Disease Control – each developed national networks of public and private hospitals to measure AR trends, prevent healthcare-associated infections (HAIs), and enhance appropriate use of antibiotics. The All India Institute of Medical Sciences is coordinating HAI measurement and prevention efforts in both networks. In addition, efforts in the state of Tamil Nadu focus on building district-level IPC capacity to prevent HAIs, focusing on maternal and neonatal patients.
The Indian Governamnet is is working closely with partners at the national and state level to:
Detect AR pathogens, including novel strains, by developing lab networks and lab expertise.
Use standardized surveillance to monitor and track AR infections in healthcare to learn how often these infections occur and to help develop strategies to prevent them.
Implement focused IPC activities and training.
Optimize use and reduce misuse of critical antibiotics through antibiotic stewardship programs.
Antibiotics
History and development of antibiotics
Decline of antibiotics
Bacteriophage: nature’s most abundant antibiotics
Phage specificity, resistance, transduction, lysis
Emergence of phages
Phage Case studies
Challenges to mainstream commercialization
Antibiotic resistance : A global concern Rohan Jagdale
As we belongs to pharma field., I curiously presented this slide for better understanding about this problem. As the world running out of antibiotics., we need to see this as one of a serious issue right now. So we need to overcome this by knowing bacterial mechanisms. They are well adapted and complicated. We as future pharmacist need to develop new antibiotics and hence we again need to look into the soils and environment in search of new bacterias for producing new antibiotic drugs.
Kumaryasava is an alcoholic Ayurvedic formulation prepared by the fermentation of Aloe vera. Flowers of Woodfordia fruticosa are added as inoculums for fermentation process.
Literature Survey Antibiotic ResistanceTuhin Samanta
Anti-toxin obstruction happens when microscopic organisms change in light of the utilization of these medications. Microscopic organisms, not people or creatures, become anti-toxin safe. These microorganisms may contaminate people and creatures, and the diseases they cause are more diligently to treat than those brought about by non-safe microscopic organisms.
The webinar and I need to know you are doing well and the proper way to wear surgical mask on the same day as the basic unit of the kidney is called onco intelligence building in
Includes definition, classification, history, formation, salient features, gene transfer( conjugation, transformation, transduction), antibiotic resistance, nutritional influence, quorum sensing, role in pathogenesis, and controversies.
Vaccine Victories Against Microbial Resistance - Dr. Donald F. GersonPnuVax
Vaccine and novel immunotherapies offer a window of opportunity to combat emerging infectious disease as well as the rising threat of antibiotic resistance.
this is a review about evolution of antibiotic resistance. I tried to answer how bacteria acquire new genes to resist, how they choose, what are people doing to prevent this increasing resistance levels.
ventilator waveforms are graphical representation of pulmonary physiology, mechanics and patient ventilator interaction. optimal patient ventilator interaction is needed to balance two goals of mechanical ventilation, safety and comfort.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
1. WAR AGAINST BACTERIAL RESISTANCE
VICTORY VS TRUCE
Dr. Ubaidur Rahaman
MD (Internal Medicine), EDIC
Internist and Critical Care Specialist
2. Here is a hypothetical illustration. Mr X has a sore throat. He buys some penicillin and gives himself,
not enough to kill the streptococci but enough to educate them to resist penicillin.
He then infects his wife. Mrs X gets pneumonia and is treated with penicillin.
As the streptococci are now resistant to penicillin the treatment fails. Mrs. X dies.
Who is primarily responsible for Mrs. X’s death?”
“The time may come when penicillin can be bought by anyone in the shops.
Then there is the danger that the ignorant man may easily under dose himself
and by exposing his microbes to non-lethal quantities of the drug make them resistant.
3. 1940 Penicillinase E. coli
Penicillin 1943
Streptomycin 1944
1947 Penicillinase R Staph
1945 Streptomycin R
Chloramphenicol and Polymyxin 1947
Erythromycin 1953
Bacitracin 1945
Tetracycline 1950
RESISTANCE AND ANTIBIOTIC DISCOVERY WALKED TOGETHER
Methicillin 1960
Ampicillin
4. 10,000
ACTINOMYCETES
SCREENED
2500 PRODUCE
ANTIBIOTIC
2250
STREPTOTHRICIN
125 STREPTOMYCIN
40 TETRACYCLINE
1/100,000
VANCOMYCIN
1/1000,000
ERYTHROMYCIN
1/10,000,000
DATPOMYCIN
Jon Clardy, Michael Fischbach, and Cameron Currie. The natural history of antibiotics.
Curr Biol. 2009 June 9; 19(11): R437–R441.
Nearly all the antibiotics discoveries, with few exception (trimethoprim, monobactams, fosfomycin and cabapenems),
were serendipitous by empirical screening not innovative.
5. Erythromycin 1953
Tetracycline 1950
RESISTANCE IS A EMERGING PROBLEM
1959 Tetracycline R Shigella
Methicillin 1960
Gentamycin 1967
Vancomycin 1972
Imipenem and Ceftazidime 1985
Levofloxacin 1996
Linezolid 2000
Ceftaroline 2010
1962 Methicillin R Staph
1968 Erythromycin R Streptococcus
1979 Gentamycin R Enterococcus
1987 Ceftazidime R Enterobacteriaceae
1988 Vancomycin R Enterococcus
1996 Levofloxacin R Pneumococcus
1998 Imipenem R Enterobacteria
2001 Linezolid R Staphylococcus
2002 Vancomycin R Staphylococcus
2004/5 PDR Acinetobacter and Pseudomonas
2009 PDR Enterobacteriaceae
2011 Ceftaroline R Staphylococcus
7. 1940 1950 1960 1970 1980 1990 2000
PENICILLINASE
DISCOVERY
ANTIBIOTIC
RESISTANCE
PLASMID
TRANSMISSIBLE
FLOUROQUINOLONE
RESISTNCE
INCREASING ANTIBIOTIC RESISTANCE
THE DARK AGE
(SEMMELWEIS)
DISENCHANTMENT
(SEMMELWEIS)
(AGAIN)
PHARMACOLOGIC BIOCHEMICAL TARGET GENOMIC HTSPRIMORDIAL GOLDEN
FDA OFFICE
OF NEW DRUG
Julian Davies* and Dorothy Davies
. Origins and Evolution of Antibiotic Resistance. MICROBIOLOGY AND MOLECULAR
BIOLOGY REVIEWS, Sept. 2010, p. 417–433
COMPLETING A FULL CIRCLE
10. DESPITE UTILIZING ANTIBIOTICS OVER MILLIONS OF YEARS,
ANTIBIOTIC RESISTANCE DID NOT DEVELOP IN WILD ENVIRONMENT OF ATTINI ANTS[9],
WHILE HUMANS COULD NOT PREVENT THIS CATASTROPHE IN JUST 80 YEARS OF USE
12. RESISTANCE IS ANCIENT
Soldier died in WW1 (March 1915)
Shigella flexneri R to Penicillin and Erythromycin
Penicillin discovered in 1929
Erythromycin discovered in 1953
Soil from beringian permafrost, place near bering strait in
Alaska
genes encoding resistance to
beta lactam, tetracycline and glycopeptide antibiotics
ESBL enzymes originated more than two billion years ago
Beta lactamase is evolving for
more than 100 million years
13. Abraham, E. P., and E. Chain. 1940. An enzyme from bacteria able to destroy penicillin.
Rev. Infect. Dis. 10:677–678.
ANTIBIOTICS AND RESISTANCE ARE PRESENT IN MICROBIAL WORLD FOR MILLENNIA,
WE ONLY ACKNOWLEDGED ITS EXISTENCE RECENTLY.
ANTIBIOTICS AND RESISTANCE ARE ANCIENT
14. WHAT IS THE ROLE OF SO CALLED ANTIBIOTICS AND RESISTANCE IN NATURE?
ANTIBIOTICS
QUORUM
SENSING
BIOFILM
FORMATION
VIRULENCE
IMMUNO-
MODULATION
ANTIBIOTICS ARE MESSENGER
RESISTANCE ARE BLOCKERS
Grace Yim, Helena Huimi Wang, Julian Davies. The truth about antibiotics.
International Journal of Medical Microbiology 296 (2006) 163–170
15. WHAT IS THE ROLE OF SO CALLED ANTIBIOTICS AND RESISTANCE IN NATURE?
Diego Romero, Matthew F. Traxler, Daniel López, Roberto Kolter. Antibiotics as Signal Molecules. Chem Rev. 2011 Sep
14; 111(9): 5492–5505.
• ABILITY TO INDUCE DIVERSE RESPONSE DEPENDING
ON CONCENTRATION USED
HORMESIS
SO CALLED ANTIBIOTICS ARE NOT MEANT FOR ANTIBIOSIS IN NATURE,
IT EXERTS THIS EFFECT ONLY IN CONCENTRATION MUCH ABOVE THAN PRESENT IN NATURE
17. 1962
SIR FRANK
MACFARLANE
BURNET
Virologist and
immunologist
“one can think of the middle of the 20th century
as the end of one of the most important social revolutions in history,
the virtual elimination of the infectious diseases as a significant factor in
social life”
Gerald B. Pier. On the Greatly Exaggerated Reports of the Death of Infectious Diseases. Clin Infect Dis 2008;47(8):1113-4
Rustam I. Aminov. The role of antibiotics and antibiotic resistance in nature. Environ Microbiol 2009;11(12), 2970-88.
BUT….. COMPLACENCY PREVAILED
1965 Dr WILLIAM J. STEWART US SURGEON GENERAL
“It is time to close the book on infectious diseases,
and declare the war against pestilence won”
18. 1968
USPUBLICHEALTHSERVICE
“The emphasis of epidemiologic investigation has shifted markedly in the
last two decades. A decline in the interest in the infectious diseases and
increase in concern with the non-infectious diseases has resulted from the
change in relative importance of these categories of disease in many parts
of the world, including the United States.
It is also recognized that, although major tasks still remain in the
improvement of control over the infectious diseases [emphasis added]. .
.the identification of cigarette smoking as the major cause of this
century’s epidemic of lung cancer. . .[and] chronic diseases. . .now
constitute the predominant health problems in this country.”
BUT….. COMPLACENCY PREVAILED
It was presumed initially, that antibiotic resistance would largely be
result of target modification through MUTATION
which will remain limited to bacterial clone by VERTICAL INHERITANCE.
19. Cell-to-cell contact was required for resistance-gene transfer, indicating that bacterial conjugation was involved.
This was subsequently confirmed by experiments that showed that blending (agitation) interfered with transfer.
Multiple antibiotic resistance of Shigella dysenteriae strains could be transferred to other Enterobacteriaceae,
simply by mixing liquid cultures of resistant and sensitive bacteria and
plating on solid medium containing the appropriate antibiotics as selective agents
WAR TORN JAPAN 1959
Epidemic multidrug resistant Shigella dysenteriae (Streptomycin, Chloramphenicol, Tetracycline,
Sulfonamide)
HGT
20. Naomi Dutta
UNITED KINGDOM 1959
multidrug resistant Salmonella typhimurium
G. LEBEK obtained evidence for transferable, multiple antibiotic resistance in Salmonella typhimurium and E. coli isolated from
children in 1960.
The presentation of his results was met with “harsh and unpleasant” criticism (his words) in Munich and
LEBEK was dismissed. He was unemployed for several months and then accepted a position in Bern,
Switzerland.
A report of his work was eventually published in 1963
Lebek G.
Uber die Enstehung mehrfachresistanter Salmonellen-
Ein experimenteller Beitrag.
Zbl. Bact., Dept. I, Orig. 1963;188:494-499.
HGT
21. BORROWER BACTERIA RESISTANCE GENE DONOR BACTERIA
CARBAPENEM R ENTEROBAC,
ACINATOBACTER, PSEUDOMONAS
blaCTX-M KLUYVERA
CARBAPENEM R ENTEROBAC,
ACINATOBACTER, PSEUDOMONAS
blaNDM ERYTHROBACTER
LITORALIS
VRSA VanA VRE
22. HGT
Plasmid carry considerable variety of genes determining
resistance to multiple antibiotics as well as genes
conferring virulence to bacterium.
23. MILLION YEARS OF MACRO EVOLUTION BY MAINLY VERTICAL GENE TRANSFER (MUTATION)
80 YEARS OF
MICRO
EVOLUTION
MAINLY BY HGT
EVOLUTION OF ANTIBIOTIC RESISTANCE AND SELECTION PRESSURE
24. PAN MICROBIOME, PANGENOME AND RESISTOME
PAN
MICROBIOME
A
B
C
D
E
F
G
H
I
J PANGENO
ME
RESISTO
ME
PANGENOME
25. GLOBAL MICROBIOME
PANGENOME PANPROTEOME
MOBILOZOME
RESISTOME PARVOME
CLINICALLY IMPORTANT
RESISTANCE GENES
CLINICALLY IMPORTANT
ANTIBIOTIC MOLECULES
HUMAN ANTIBIOTIC
PRODUCTION
Gillings MR. Evolutionary consequences of antibiotic use for the resistome, mobilome and
microbial pangenome. Front Microbiol. 2013 Jan 22;4:4.
CONCEPTUAL REPRESENTATION OF THE BIOLOGICAL MOLECULES
OF RELEVANCE TO ANTIBIOTIC RESISTANCE.
26. CLINICAL ECOSYSTEM
HIGH SELECTION PRESSURE
NON-CLINICAL ECOSYSTEM
MODERATE SELECTION PRESSURE
ENVIRONMENTAL ECOSYSTEM
RESISTOME
Eileen R. Choffnes, David A. Relman, Alison Mack. Antibiotic resistance: implications for global health and novel intervention strategies:
workshop summary rapporteurs; Forum on Microbial Threats, Board on Global Health, Institute of Medicine of the National Academies.
United States: Washington D.C. National Academies Press; 2010.
EXPANSION OF RESISTOME
28. WATER TREATMENT PLANT/ SEWER
RIVER/ SOIL
EXPANSION OF ENVIRONMENT RESISTOME
ANTIBIOTIC RESISTANCE AND WASTE DISPOSAL
29.
30. CLINICAL ECOSYSTEM
HIGH SELECTION PRESSURE
NON-CLINICAL ECOSYSTEM
MODERATE SELECTION PRESSURE
ENVIRONMENTAL ECOSYSTEM
RESISTOME
Eileen R. Choffnes, David A. Relman, Alison Mack. Antibiotic resistance: implications for global health and novel intervention strategies:
workshop summary rapporteurs; Forum on Microbial Threats, Board on Global Health, Institute of Medicine of the National Academies.
United States: Washington D.C. National Academies Press; 2010.
EXPANSION OF RESISTOME
31. BREACH IC
HAI
INJUDICIOUS
ANTIBIOTICS
AMR
RESISTANT
MICROBIOTIA OF
SKIN AND GIT
RESISTANT MICROBIOTA
OF ENVIRONMENT/
SURFACE
BREACHED IC
SPREAD TO
OTHER
PATIENTS
PATIENT DISCHARGED
SPREADS RESISTANT MICROBIOTA-
CONTACT / FEACES
EXPANSION OF COMMUNITY
RESISTOME
PATIENT ADMITTED TO HOSPITAL
32. Help us
from
antibiotic
pollution
These humans
polluted our
environment with
our secondary
metabolites
Not to worry mates.
Borrow these
variety of resistance
genes
How come man forget,
We produce antibiotics as well
as resistance.
they are unleashing havoc on
our siblings with weapon
provided by us.
We will enrich our colleagues
with counter weapons
They call it
antibiotics
Our genes will prevail
over humans wits
AMP
C
MBL
MRSA
MBL
AMP
C
BACTERIAL SOCIAL SECURITY SYSTEM
33. “Long term harm to self, others and environment,
when unrestrained individual behavior
to maximize personal short-term gain,
results in depletion or devastation of resources”
34. ANTIBIOTICS ARE SOCIETAL DRUGS
The collateral damage of misuse of antibiotics on one patient is
not limited to that patient, but affects whole society,
through expansion of environmental resistome.
35. FROM FRIEND TO FOE Pseudomonas
Acinatobacter
Legionella
Strenotrophomonas
EVOLUTION OF NEW PATHOGENS
HOW BENIGN COMMENSALS/ ENVIRONMENTAL BACTERIA TURN INTO DREADED PATHOGENS
Bacteria can evolve rapidly to adapt to environmental change.
When the "environment" is the immune response of an infected host, this evolution can turn
harmless bacteria into life-threatening pathogens
Miskinyte M, Sousa A, Ramiro RS, de Sousa JAM, Kotlinowski J, Caramalho I, Magalhães S, Soares MP and Gordo I. The Genetic Basis of
Escherichia coli Pathoadaptation to Macrophages. PLoS Pathog, 9(12): e1003802
36. VIRULENCE VS RESISTANCE
RESISTANCE COMES AT EVOLUTIONARY COST OF VIRULENCE
RESISTANCE GENE VIRULENC GENE
COMBIPACK
Beceiro A, Tomás M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the
bacterial world?. Clin Microbiol Rev. 2013;26(2):185-230.
HGT
37. WHO WILL WIN THE WAR? OUR WITS VERSUS THEIR GENES
“FUTURE OF HUMANITY AND MICROBES LIKELY WILL UNFOLD
AS EPISODES OF A SUSPENSE THRILLER THAT COULD BE TITLED
‘OUR WITS VERSUS THEIR GENES’”
“As the climax is arriving, it is becoming more evident that
our wits of discovering secondary metabolites of bacteria,
and tinkering, producing and using it as antibiotic in exuberant amount,
cannot not keep pace with bacterial ability to manipulate its genetic pool of resistance”
40. SOLUTION- VICTORY VERSUS TRUCE
ANY ANTIBIOTIC THAT WOULD BE DISCOVERED IN FUTURE,
RESISTANCE AGAINST IT WOULD ALREADY BE EXISTING IN MICROBIAL WORLD,
WHICH WILL BE ACQUIRED BY THE TARGET BACTERIA SOONER OR LATER.
EXPANSION OF
ENVIRONMETAL
RESISTOME
ANTIBIOTIC SELECTION PRESSURE
41. SOLUTION- VICTORY VERSUS TRUCE
• STOP ANTIBIOTIC USE
• ELIMINATE SELECTION PRESSURE
VICTORY
IMPOSSIBLE
• PREVENT INFECTION AND
JUDICIOUS ANTIBIOTIC USE
• REDUCE SELECTION PRESSURE
TRUCE
POSSIBLE
• PREVENT INFECTION – INFECTION CONTROL
• JUDICIOUS USE OF ANTIBIOTIC- ANTIBIOTIC STEWARDSHIP PROGRAM
• DICOURAGE ANTIBIOTIC USE IN ANIMALS AND AGRICULTURE
TRUCE
42. MILLION YEARS OF MACRO EVOLUTION BY MAINLY VERTICAL GENE
TRANSFER (MUTATION)
80 YEARS OF
MICRO
EVOLUTION
MAINLY BY
HGT
TRUCE
MINIMIZE
EVOLUTIONARY
PRESSURE
MINIMIZE EXPANSION
OF RESISTOME
43. INFECTION
CONTROL
STANDARD PRECAUTION
TRANSMISSION BASED
PRECAUTION
• (STANDARD, DROPLET AND
AIRBORNE)
HAND HYGEINE
PPE
ENVIRONMENTAL CLEANING
COUGH ETIQUETTES
ANTIBIOTIC
STEWARDSHIP
RIGHT DRUG
RIGHT DOSE
DE-ESCALATION
RIGHT DURATION
PHARMACOKINETIC/
DYNAMICS
HOSPITAL ANTIBIOGRAM
ANTIBIOTIC SENSITIVITY
TESTING
GOVERNMENT
REGULATING AGENCY
PHARMACEUTICAL
INDUSTRY
must be reflected in
clinical examination,
nursing care and
invasive procedure
Maximize clinical outcome
and minimize collateral
damage
44. Yong, Ed. I Contain Multitudes: The Microbes Within Us and a Grander View
of Life (Kindle Location 1). Random House. Kindle Edition.
Editor's Notes
For a short period of time, drug company chemists managed to keep ahead in the race against antibiotic resistance by making slight changes in the structures of their antibiotics. The synthesis of semi-synthetic methicillin, which was β-lactamase stable, temporarily rescued the failure of the penicillin (142). Meanwhile, the production of ampicillin, another semi-synthetic β- lactam antibiotic, inhibited a wide range of Gram-negative organisms, including Escherichia coli, Haemophilus influenzae, Salmonella Typhi and Shigella. As a result of the explosive antibiotic development, the market was crowded with more than one hundred antibacterial agents (143). Thinking that they had won a total victory, many pharmaceutical firms started to withdraw the efforts to develop new antibiotics in the 1980s, instead focusing on drugs for chronic illnesses such as heart disease, cancer and diabetes, the leading causes of mortality and morbidity in developed countries (128). Thus far, antibiotics have been used with unrestrained passion far surpassing the needs of management and infection control.
Some antibiotic gene clusters are cosmopolitan, while others have cameo roles. One analysis
estimated that if 10,000 actinomycetes (the family of soil bacteria that has produced most of
our antibiotics and other medically useful molecules) were screened, 2,500 would produce
antibiotics. Of these, 2,250 would make streptothricin, 125 streptomycin, and 40 tetracycline.
Vancomycin is predicted to be made by one in a hundred thousand; erythromycin, by one in a
million; and daptomycin, our newest antibiotic, by one in ten million. Because the soil bacteria
that produced so many of our antibiotics live in exceptionally complex multispecies
environments, tracing both neighbors and ancestors will be a daunting task.
History of antibiotic discovery and concomitant development of antibiotic resistance. The dark ages, the preantibiotic era; primordial,
the advent of chemotherapy, via the sulfonamides; golden, the halcyon years when most of the antibiotics used today were discovered; the lean
years, the low point of new antibiotic discovery and development; pharmacologic, attempts were made to understand and improve the use of
antibiotics by dosing, administration, etc.; biochemical, knowledge of the biochemical actions of antibiotics and resistance mechanisms led to
chemical modification studies to avoid resistance; target, mode-of-action and genetic studies led to efforts to design new compounds; genomic/HTS,
genome sequencing methodology was used to predict essential targets for incorporation into high-throughput screening assays; disenchantment,
with the failure of the enormous investment in genome-based methods, many companies discontinued their discovery programs. Other milestones
in this history include the creation of the FDA Office of New Drugs after the thalidomide disaster led to stricter requirements for drug safety,
including the use of antibiotics. This slowed the registration of novel compounds. Before antibiotics were discovered, Semmelweis advocated hand
washing as a way of avoiding infection; this practice is now strongly recommended as a method to prevent transmission.
ATTINI ANTS, SCOVOSPIS A FUNGUS PARASITE, ACTINOMYCES BACTERIA
Roughly 50 million years ago in South America, a lone species of ant abandoned its primitive hunter–gatherer ways and, in a unique event in ant evolution, adopted an agrarian lifestyle. Entering into a partnership with a parasol mushroom, these agricultural pioneers learned to weed, manure and propagate their fungal crops, ensuring a reliable source of food. From this innovative ancestral stock arose the ant group Attini, of which there are now about 210 species, largely concentrated in wet, South American forests. The Attini include the well-known leaf cutting ants, in which the association (or ‘symbiosis’) between ants and fungi has become enormously successful. Colonies of some Atta species may contain eight million ants, with the collective biomass of an adult cow. These ants cut a cow’s daily requirement of fresh vegetation, but they do not directly consume it. Instead, by chewing it into a pulp, they convert the vegetation into a substrate on which their fungal crops are grown. The fungus, in turn, produces specialized structures known as gongylidia, which serve as food for the ants. This arrangement has been called an “unholy alliance”1, because it combines the ants’ ability to circumvent plant antifungal defences (such as the waxy coatings of leaves, which the ants scrape away) with the ability of the fungus to subvert plant anti-insect defences (such as chemical insecticides, which are digested by the fungus, so are absent from the fungal tissue consumed by the ants).
scovopsis is held in check by specific antibiotics produced by bacteria living on the bodies of the ants. It seems hardly a coincidence that these bacteria belong to the genus Streptomyces, from which over half of the antibiotics used by humans are derived. Like the parallels between ant and human agriculture 9 , understanding this use of antibiotics by ants could be directly relevant to human survival. For example, whereas humans have been using antibiotics for fewer than 60 years (longer if you consider the medicinal use of moulds in the ancient Far East, or among the Greeks and Romans), ants have been using them for 50 million years.
Soil bacteria possesses the ability to make antibiotics, as well as to live with antibiotics. Bacteria have been exposed to antibiotics produced by other competing microorganisms for millennia. Antibiotic resistance genes have a long evolutionary history predating well before the discovery and exposure of antibiotics in concentration much above that produced in nature and resultant selection pressure.
Many biosynthetic gene clusters that make “antibiotics” are also known contain genes that confer “resistance” to those same antibiotics.
The common resource of antibiotics is not meant for antibiosis in nature, rather they exert this effect when applied at unnaturally high concentrations and bacteria combat this environmental pollution with expression of resistance. Injudicious use of antibiotics in humans, agriculture and animal husbandry has resulted in selection and spread of resistance in clinical, commensal as well as environmental bacteria
in 1959-60, it was found that the multiple antibiotic resistance of Shigella dysenteriae strains could be transferred to other Enterobacteriaceae, simply by mixing liquid cultures of resistant and sensitive bacteria and plating on solid medium containing the appropriate antibiotics as selective agents (OCHIAeIt al. 1959; AKIBA et al. 1960). The mechanism by which the transfer occurred was revealed when the laboratories of s. MITSUHASHI (HARADA et al. 1960), R. NAKAY(ANA KAYAa nd NAKAMURA19 60a), and T. WATANABE (WATANABanEd FUKUSAW1A96 0a) all showedt hat cell-to-cell contact was required for resistance-gene transfer, indicating that bacterial conjugation was involved. This was subsequently confirmed by experiments that showed that blending (agitation) interfered with transfer and that acridine orange treatmoefn t m ultiply resistant strains caused loss of the resistance determinants
But discovery of horizontal transfer (HGT) of resistance genes via plasmid came out to be fundamental challenge to this model. Plasmid carry considerable variety of genes determining resistance to multiple antibiotics as well as genes conferring virulence to bacterium. HGT enables bacteria to share resistant genes between themselves as survival tool.[21] This pool of vertically transmitted genes accrued over million years of evolutionary advantage, can be distributed horizontally in a single generation under antibiotic selection pressure, via HGT.
This sharing of genes is so ubiquitous that entire bacterial world can be considered a pan organism containing pangenome[22]. Part of pangenome encoding resistance is termed as resistome, a common pool shared between all bacteria, benign or pathogenic, native to soil, animal or human[
The small cross-hatched boxes represent the antibiotics and resistance genes of relevance to clinical practice. Respectively, these are a small subset of the world of small bioactive molecules (the parvome), and the world of potential resistance determinants (the resistome). The resistome comprises the genes that potentially encode resistance to antibiotics. The mobilome comprises the mobile proportion of bacterial genomes. The mobilome and resistome overlap, since many resistance genes are located on mobile elements. Both the resistome and mobilome are a subset of the total coding capacity of prokaryotic cells, the pangenome, which is expressed as the panproteome. Note that only a small proportion of the parvome is utilized by humans for antibiotic purposes, and that the scale of commercial antibiotic production probably overwhelms the natural production of these molecules by the entire global microbiota.
Antibiotic prescription review of multiple hospitals in 10 U.S. states expressed need to improve antibiotic prescribing in 37% of cases[29]. Data have revealed that in intensive care units 30% to 60% of prescribed antibiotics have been found to be unnecessary and inappropriate
In agriculture and animal husbandry use of antibiotics for infection prevention and growth promotion should be strongly discouraged and vaccination and improved hygiene and welfare practices should be promoted. Antibiotics should be given for treating infection under veterinary supervision
But discovery of horizontal transfer (HGT) of resistance genes via plasmid came out to be fundamental challenge to this model. Plasmid carry considerable variety of genes determining resistance to multiple antibiotics as well as genes conferring virulence to bacterium. HGT enables bacteria to share resistant genes between themselves as survival tool.[21] This pool of vertically transmitted genes accrued over million years of evolutionary advantage, can be distributed horizontally in a single generation under antibiotic selection pressure, via HGT.